Sarcoma in Paget disease of bone: Clinical, radiologic, and pathologic features in 22 cases

T. E. Moore, A. R. King, M. H. Kathol, G. Y. El-Khoury, R. Palmer, P. R. Downey

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

The clinical, radiologic, and histologic features of 22 cases of Paget sarcoma were reviewed to determine in which patients with Paget disease these tumors are most likely to develop and what radiologic findings suggest the diagnosis. Clinical findings at presentation included pain and/or a mass (11 patients), pathologic fracture (seven), and neurologic symptoms (four). Survival time in 20 patients ranged from 5 days to 2.5 years. Two patients were lost to follow-up: one at 2 years and one at 8 years. There were 16 high-grade osteosarcomas, three chondrosarcomas, two fibrosarcomas, and one malignant fibrous histiocytoma. The most common site was the femur. Tumors also were observed in unusual sites. In one case of multifocal osteosarcoma, the tumor involved only pagetic bone. In 15 patients, Paget disease was polyostotic, clinically significant, and had been documented previously. In four patients, a sarcoma developed near the site of a fracture that had occurred between 2 months and 15 years previously. All cases showed radiologic evidence of a destructive lesion; other findings included a mass and evidence of tumor mineralization. Periosteal reaction was not observed. All but one tumor developed in a site of osteoblastic or mixed osteoblastic and lytic Paget disease. Our results suggest that sarcomas can develop in any part of any bone affected by Paget disease but are more likely to occur with advanced disease and to present with a destructive lesion without periosteal reaction.

Original languageEnglish (US)
Pages (from-to)1199-1203
Number of pages5
JournalAmerican Journal of Roentgenology
Volume156
Issue number6
DOIs
StatePublished - Jan 1 1991

Fingerprint

Osteitis Deformans
Sarcoma
Osteosarcoma
Neoplasms
Malignant Fibrous Histiocytoma
Spontaneous Fractures
Chondrosarcoma
Fibrosarcoma
Lost to Follow-Up
Neurologic Manifestations
Femur
Bone and Bones
Pain
Survival

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Sarcoma in Paget disease of bone : Clinical, radiologic, and pathologic features in 22 cases. / Moore, T. E.; King, A. R.; Kathol, M. H.; El-Khoury, G. Y.; Palmer, R.; Downey, P. R.

In: American Journal of Roentgenology, Vol. 156, No. 6, 01.01.1991, p. 1199-1203.

Research output: Contribution to journalArticle

Moore, T. E. ; King, A. R. ; Kathol, M. H. ; El-Khoury, G. Y. ; Palmer, R. ; Downey, P. R. / Sarcoma in Paget disease of bone : Clinical, radiologic, and pathologic features in 22 cases. In: American Journal of Roentgenology. 1991 ; Vol. 156, No. 6. pp. 1199-1203.
@article{5060dcdc405b48d79e04c73ead021b14,
title = "Sarcoma in Paget disease of bone: Clinical, radiologic, and pathologic features in 22 cases",
abstract = "The clinical, radiologic, and histologic features of 22 cases of Paget sarcoma were reviewed to determine in which patients with Paget disease these tumors are most likely to develop and what radiologic findings suggest the diagnosis. Clinical findings at presentation included pain and/or a mass (11 patients), pathologic fracture (seven), and neurologic symptoms (four). Survival time in 20 patients ranged from 5 days to 2.5 years. Two patients were lost to follow-up: one at 2 years and one at 8 years. There were 16 high-grade osteosarcomas, three chondrosarcomas, two fibrosarcomas, and one malignant fibrous histiocytoma. The most common site was the femur. Tumors also were observed in unusual sites. In one case of multifocal osteosarcoma, the tumor involved only pagetic bone. In 15 patients, Paget disease was polyostotic, clinically significant, and had been documented previously. In four patients, a sarcoma developed near the site of a fracture that had occurred between 2 months and 15 years previously. All cases showed radiologic evidence of a destructive lesion; other findings included a mass and evidence of tumor mineralization. Periosteal reaction was not observed. All but one tumor developed in a site of osteoblastic or mixed osteoblastic and lytic Paget disease. Our results suggest that sarcomas can develop in any part of any bone affected by Paget disease but are more likely to occur with advanced disease and to present with a destructive lesion without periosteal reaction.",
author = "Moore, {T. E.} and King, {A. R.} and Kathol, {M. H.} and El-Khoury, {G. Y.} and R. Palmer and Downey, {P. R.}",
year = "1991",
month = "1",
day = "1",
doi = "10.2214/ajr.156.6.2028867",
language = "English (US)",
volume = "156",
pages = "1199--1203",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",

}

TY - JOUR

T1 - Sarcoma in Paget disease of bone

T2 - Clinical, radiologic, and pathologic features in 22 cases

AU - Moore, T. E.

AU - King, A. R.

AU - Kathol, M. H.

AU - El-Khoury, G. Y.

AU - Palmer, R.

AU - Downey, P. R.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The clinical, radiologic, and histologic features of 22 cases of Paget sarcoma were reviewed to determine in which patients with Paget disease these tumors are most likely to develop and what radiologic findings suggest the diagnosis. Clinical findings at presentation included pain and/or a mass (11 patients), pathologic fracture (seven), and neurologic symptoms (four). Survival time in 20 patients ranged from 5 days to 2.5 years. Two patients were lost to follow-up: one at 2 years and one at 8 years. There were 16 high-grade osteosarcomas, three chondrosarcomas, two fibrosarcomas, and one malignant fibrous histiocytoma. The most common site was the femur. Tumors also were observed in unusual sites. In one case of multifocal osteosarcoma, the tumor involved only pagetic bone. In 15 patients, Paget disease was polyostotic, clinically significant, and had been documented previously. In four patients, a sarcoma developed near the site of a fracture that had occurred between 2 months and 15 years previously. All cases showed radiologic evidence of a destructive lesion; other findings included a mass and evidence of tumor mineralization. Periosteal reaction was not observed. All but one tumor developed in a site of osteoblastic or mixed osteoblastic and lytic Paget disease. Our results suggest that sarcomas can develop in any part of any bone affected by Paget disease but are more likely to occur with advanced disease and to present with a destructive lesion without periosteal reaction.

AB - The clinical, radiologic, and histologic features of 22 cases of Paget sarcoma were reviewed to determine in which patients with Paget disease these tumors are most likely to develop and what radiologic findings suggest the diagnosis. Clinical findings at presentation included pain and/or a mass (11 patients), pathologic fracture (seven), and neurologic symptoms (four). Survival time in 20 patients ranged from 5 days to 2.5 years. Two patients were lost to follow-up: one at 2 years and one at 8 years. There were 16 high-grade osteosarcomas, three chondrosarcomas, two fibrosarcomas, and one malignant fibrous histiocytoma. The most common site was the femur. Tumors also were observed in unusual sites. In one case of multifocal osteosarcoma, the tumor involved only pagetic bone. In 15 patients, Paget disease was polyostotic, clinically significant, and had been documented previously. In four patients, a sarcoma developed near the site of a fracture that had occurred between 2 months and 15 years previously. All cases showed radiologic evidence of a destructive lesion; other findings included a mass and evidence of tumor mineralization. Periosteal reaction was not observed. All but one tumor developed in a site of osteoblastic or mixed osteoblastic and lytic Paget disease. Our results suggest that sarcomas can develop in any part of any bone affected by Paget disease but are more likely to occur with advanced disease and to present with a destructive lesion without periosteal reaction.

UR - http://www.scopus.com/inward/record.url?scp=0025771583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025771583&partnerID=8YFLogxK

U2 - 10.2214/ajr.156.6.2028867

DO - 10.2214/ajr.156.6.2028867

M3 - Article

C2 - 2028867

AN - SCOPUS:0025771583

VL - 156

SP - 1199

EP - 1203

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 6

ER -